IXI raises $36.5M from Amazon and more to bring the concept of autofocus to prescription glasses

A startup from Finland is revolutionizing the prescription eyewear market with cutting-edge technology. IXI is developing low-power glasses that use eye-tracking and liquid crystal lens technology to automatically adjust for Presbyopia (far-sightedness) for the wearer.

After four years in stealth mode, Helsinki-based IXI has raised $36.5 million from investors like the Amazon Alexa fund to bring its innovative product to market.

Led by CEO Niko Eiden and Chief Algorithm Officer Ville Miettinen, IXI is tapping into the vast potential of the eyewear market, estimated at over $200 billion and growing rapidly.

The team behind IXI previously worked on groundbreaking mobile technology at Nokia and later founded Varjo, a mixed-reality headset developer targeting the enterprise market.

IXI’s focus on utilizing technology to improve eyesight sets it apart from other AR and VR companies in the eyewear space, with a strong emphasis on addressing vision correction as a crucial medical need.

IXI’s innovative eyewear features eye-tracking technology and liquid crystal lenses that automatically adjust to provide clear vision for the wearer. This advancement aims to simplify the experience for users who currently need multiple pairs of glasses or use varifocals.

With a focus on user convenience and improved vision, IXI’s glasses offer near-sighted prescriptions built into the lenses and an estimated two-day battery life.

While other companies are exploring autofocus eyewear, IXI’s expertise and commitment to seamless design set it apart in the industry.

Investors are enthusiastic about IXI’s potential to revolutionize the eyewear market and enhance human eyesight, citing the team’s European hardware expertise and track record of innovation.

With a strong foundation in advanced optics and eye-tracking technology, IXI is poised to shape the future of vision correction and redefine how we perceive the world.